Demars Financial Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.78M Buy
30,977
+5,541
+22% +$318K 0.49% 26
2026
Q1
$1.54M Sell
25,436
-1,143
-4% -$66.6K 0.51% 25
2025
Q4
$1.43M Buy
26,579
+1,207
+5% +$58.1K 0.48% 22
2025
Q3
$1.14M Buy
25,372
+7,384
+41% +$345K 0.4% 25
2025
Q2
$833K Sell
17,988
-948,199
-98% -$46.5M 0.32% 30
2025
Q1
$15.8M Buy
966,187
+84,545
+10% +$4.93M 0.45% 26
2024
Q4
$15.6M Buy
+881,642
New +$49.3M 0.5% 26
2024
Q2
Sell
-5,153
Closed -$279K 68
2024
Q1
$279K Sell
5,153
-9,898
-66% -$504K 0.14% 57
2023
Q4
$772K Sell
15,051
-62,519
-81% -$3.28M 0.41% 24
2023
Q3
$4.5M Buy
77,570
+7,366
+10% +$451K 2.58% 8
2023
Q2
$4.49M Sell
70,204
-347
-0.5% -$23.3K 2.49% 14
2023
Q1
$4.89M Buy
70,551
+8,628
+14% +$609K 2.69% 8
2022
Q4
$4.46M Sell
61,923
-4,231
-6% -$319K 2.46% 12
2022
Q3
$4.7M Buy
66,154
+2,713
+4% +$197K 2.79% 6
2022
Q2
$4.88M Sell
63,441
-6,541
-9% -$498K 2.78% 10
2022
Q1
$5.11M Buy
69,982
+7,936
+13% +$533K 2.57% 9
2021
Q4
$3.87M Buy
62,046
+4,082
+7% +$239K 2.05% 17
2021
Q3
$3.43M Buy
57,964
+54,255
+1,463% +$3.57M 2.02% 21
2021
Q2
$248K Buy
+3,709
New +$242K 0.15% 77

Other funds holding BMY

Demars Financial Group's BMY Position: Q2 2026 in Review

Demars Financial Group increased its Bristol-Myers Squibb (BMY) stake by 22% in Q2 2026, buying an estimated $318K and bringing the position to 30,977 shares worth $1.78M. The position accounts for 0.49% of the portfolio, ranked #26.

Demars Financial Group first reported a position in BMY in Q2 2021 and has held it in 19 quarters since. The position peaked at $15.8M in Q1 2025. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Demars Financial Group held 30,977 shares of Bristol-Myers Squibb worth $1.78M as of Q2 2026.
  • Demars Financial Group bought 5,541 Bristol-Myers Squibb shares in Q2 2026, an estimated $318K.
  • Bristol-Myers Squibb made up 0.49% of Demars Financial Group's portfolio in Q2 2026, its #26 holding.
  • Demars Financial Group first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 19 quarters since.
  • Demars Financial Group's Bristol-Myers Squibb position peaked at $15.8M in Q1 2025.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Demars Financial Group's 13F filing for Q2 2026, filed 21 Jul 2026.